婴儿期感染与抗生素使用及儿童肥胖风险:一项纵向出生队列研究
该纵向出生队列研究纳入1997年1月1日至2013年3月31日出生的260556名婴儿,分析婴儿期感染与抗生素使用对儿童肥胖风险的影响。控制混杂因素后,婴儿期无抗生素使用的感染与儿童肥胖风险升高相关(OR 1.25,95%CI 1.20-1.29),而抗生素使用与未治疗感染相比无显著关联(1.01,0.98-1.04)。
要点
- 婴儿期感染(未用抗生素)与儿童肥胖风险升高相关(OR 1.25,95%CI 1.20-1.29)。
- 婴儿期抗生素使用与未治疗感染相比,与儿童肥胖风险无显著关联(OR 1.01,95%CI 0.98-1.04)。
- 感染次数与儿童肥胖风险呈明确剂量反应关系(ptrend<0.0001)。
核心结论
- 婴儿期感染而非抗生素使用与儿童肥胖风险相关。
- 该发现需在未來研究中重复验证。
- 结果不能排除抗生素对微生物组组成的潜在影响,抗生素使用应始终审慎,但提示婴儿期用抗生素治疗常见感染不太可能是儿童肥胖的主要贡献因素。
研究设计与样本
- 纵向出生队列研究,纳入1997年1月1日至2013年3月31日出生于Kaiser Permanente Northern California人群的婴儿。
- 共纳入260556名个体,使用电子病历获取抗生素使用、感染诊断和人体测量数据(至18岁)。
- 采用标准混合效应逻辑回归分析每名儿童多次BMI测量(中位数5次),计算肥胖风险的OR和95%CI。
- 另在547对暴露状态不一致的同性别双胞胎中进行了子研究以验证发现。
主要发现
- 控制母亲年龄、种族或族裔、孕前BMI、早产、低出生体重、母亲抗生素使用及孕期感染后,婴儿期无抗生素使用的感染与无感染对照相比,儿童肥胖风险升高(OR 1.25,95%CI 1.20-1.29)。
- 感染次数与儿童肥胖风险呈明确剂量反应关系(ptrend<0.0001)。
- 与未治疗感染的婴儿相比,婴儿期抗生素使用与儿童肥胖风险无显著关联(OR 1.01,95%CI 0.98-1.04)。
- 广谱和窄谱抗生素均与儿童肥胖风险无显著关联。
- 双胞胎集分析结果支持上述发现。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出该发现需在未來研究中重复验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data from previous studies have suggested a possible association between antibiotic use in infancy and risk of childhood obesity, with implications for health-care delivery and obesity prevention strategies. However, whether the observed association was due to antibiotic use or underlying infection, or both, is unclear. We aimed to disentangle the effect of antibiotic use in infancy from that of underlying infection on the risk of childhood obesity. METHODS: In this longitudinal birth cohort study, we included infants in the Kaiser Permanente Northern California population born between Jan 1, 1997, and March 31, 2013. We used electronic medical records to ascertain data for antibiotic use, infection diagnosis, and anthropometric measurements (and thus BMI and obesity status) from birth up to age 18 years. We used standard mixed-effects logistic regression for repeated measurements to analyse multiple BMI measurements per child (median five measurements) and to obtain odds ratios (ORs) and 95% CIs for obesity risk. We also did a substudy in 547 same-sex twin pairs with discordant exposure status to substantiate our findings. FINDINGS: 260 556 individuals were included in our analysis. After controlling for maternal age, race or ethnic origin, pre-pregnancy BMI, preterm delivery, low birthweight, maternal antibiotic use, and infection during pregnancy, infection without antibiotic use in infancy was associated with an increased risk of childhood obesity compared with controls without infection (OR 1·25, 95% CI 1·20-1·29). A clear dose-response relation was seen between infection episodes and risk of childhood obesity (ptrend <0·0001). By contrast, compared with infants with untreated infection, antibiotic use during infancy was not associated with risk of childhood obesity (1·01, 0·98-1·04). Neither broad-spectrum nor narrow-spectrum antibiotics were associated with risk of childhood obesity. These findings were supported by the results of the twin set analysis. INTERPRETATION: Infection, but not antibiotic use, during infancy is associated with risk of childhood obesity. This finding will need to be replicated in future studies. Although our results do not rule out a potential effect of antibiotics on microbiome composition and the use of antibiotics should always be judicious, they suggest that treatment of common infections with antibiotics in infancy is unlikely to be a main contributor to childhood obesity. FUNDING: Kaiser Permanente Center for Effectiveness & Safety Research.
引用
- Li DK, Chen H, Ferber J, et al. Infection and antibiotic use in infancy and risk of childhood obesity: a longitudinal birth cohort study. Lancet Diabetes Endocrinol. 2016. PMID: 27815091. doi:10.1016/S2213-8587(16)30281-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。